Across TCGA pan-cancer cohorts, RNU6-771P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNU6-771P data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher RNU6-771P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-771P expression acts as an unfavorable survival marker.

CESC, LUAD, and LGG are the cancer types where RNU6-771P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	II,III,IV	0.095	0.830	<.001	126	view →
LUAD	OS	Tertile	All	0.141	0.788	<.001	54	view →
LGG	OS	Tertile	All	0.591	0.896	.008	12	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RNU6-771P tumor-vs-normal RNA expression · all RNU6-771P data types